Definitive Proxy Filed for Critical Reverse Stock Split Vote
CTSO sits 24% above its 52-week low of $0.37 on light trading volume (0.4× avg).
Summary
Cytosorbents has filed its definitive proxy statement, setting an August 13, 2026, shareholder vote on a reverse stock split (1-for-5 to 1-for-20) to maintain its Nasdaq listing.
Key Events · Corporate Governance and Compliance · CTSO
-
Shareholder Meeting Scheduled
The company has scheduled its Annual Meeting for August 13, 2026, where key proposals will be voted upon.
-
Reverse Stock Split Vote Confirmed
Shareholders will vote on a proposal to amend the Certificate of Incorporation to effect a reverse stock split, with a ratio between 1-for-5 and 1-for-20, at the Board's discretion.
-
Critical for Nasdaq Compliance
This vote is crucial for the company to regain compliance with Nasdaq's minimum bid price requirement and avoid delisting, following a recent 180-day extension.
Analysis · CTSO · Industrial Applications And Services
Cytosorbents has filed its definitive proxy statement, formalizing the August 13, 2026, shareholder meeting where a vote on a reverse stock split will take place. This vote is critical for the company's ability to maintain its Nasdaq listing, especially following a recent 180-day extension to regain compliance with the $1.00 minimum bid price rule. While a reverse split is generally viewed negatively due to its dilutive nature and often signals underlying financial distress, it is a necessary step to avoid delisting, which would severely impact the company's liquidity and investor confidence. The outcome of this vote is a key determinant for the company's immediate future, particularly in light of its ongoing 'going concern' warnings and liquidity challenges.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 46.1% of the 284 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTSO was trading at $0.46 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $28.9M. The 52-week trading range was $0.37 to $1.30. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.